Grant: Idea to Innovation
University of Toronto
$14,888.00
Market Assessment for an interface between the nervous system and ML-based digital computation to enable nervous system repair and augmentation.
FY 2021-22
Summary
We have developed ANIMO, the Adaptive Neural Implant for Modulation and Observation. ANIMO is a vessel to implant our proprietary machine learning and neuromodulation technology within the nervous system to interpret neural activity and to respond using electrical neurostimulation. We aim to deploy ANIMO as the solution for uncontrolled seizures in veterinary healthcare. The device is suitable for over 2.5 million drug-refractory candidates, and with an anticipated procedure cost of $10,000, a multi-billion-dollar potential market exists. When just considering insured cases of drug-refractory epilepsy alone (estimated to be about 2.5% of cases), the potential addressable market size is $720M. We have formed a strategic distribution partnership with one of the most advanced veterinary hospitals in Canada, Animal Health Partners.We have clarified our value proposition as providing a device which offers the only solution for uncontrolled seizures in veterinary healthcare. We have identified the drug-refractory canine epilepsy market segment as our primary target. The purpose of our request for enlist professional consultant services to validate and expand on our preliminary market assessment.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
571000-2022
Name nom
Valiante, Taufik
Department département
Surgery
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
14888
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Market Assessment for an interface between the nervous system and ML-based digital computation to enable nervous system repair and augmentation.
Keyword
NSERC
Application summary
We have developed ANIMO, the Adaptive Neural Implant for Modulation and Observation. ANIMO is a vessel to implant our proprietary machine learning and neuromodulation technology within the nervous system to interpret neural activity and to respond using electrical neurostimulation. We aim to deploy ANIMO as the solution for uncontrolled seizures in veterinary healthcare. The device is suitable for over 2.5 million drug-refractory candidates, and with an anticipated procedure cost of $10,000, a multi-billion-dollar potential market exists. When just considering insured cases of drug-refractory epilepsy alone (estimated to be about 2.5% of cases), the potential addressable market size is $720M. We have formed a strategic distribution partnership with one of the most advanced veterinary hospitals in Canada, Animal Health Partners.We have clarified our value proposition as providing a device which offers the only solution for uncontrolled seizures in veterinary healthcare. We have identified the drug-refractory canine epilepsy market segment as our primary target. The purpose of our request for enlist professional consultant services to validate and expand on our preliminary market assessment.